Many technologies have dual-use potential, having both civilian and defence or military applications. Technologies originally developed for civilian applications may be subsequently exploited for defence or military applications. Alternatively, technologies may be developed via a ‘dual use by design’ approach, integrating dual-use directly into their development.
READ MORE
Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
This webinar covers filing priority applications, inventors and owners, the international (PCT) patent application process and filing foreign patent applications.
In the first episode of Season 2 of The IP Podcast, Dehns Partner Tim Wilson takes a look at NFTs and the main IP issues surrounding them.
The Genetic Technology Bill – announced on the 25 May 2022 by the Department for Environment, Food and Rural Affairs (Defra) – aims to take advantage of the UK’s post-Brexit position and relax the regulation around precision breeding.
When justice needs to be seen to be done: A case analysis of ABP Technology Ltd v Voyetra Turtle Beach.
Paul Harris, Head of Litigation at Dehns, discusses a trial of an account of profits.
In this article, Paul Harris, Dehns’ Head of Litigation, reviews the recent Wineapp Ltd v Johnson case.
In this article, Paul Harris, Dehns’ Head of Litigation, reviews the recent Evans V Joseph Joseph Ltd case which considers the licensing of design rights and the burden of protection.
Paul Harris, Head of Litigation at Dehns, discusses a rare case which highlights the need for caution in both drafting around prior art provided by the inventor/applicant and giving validity opinions on the same.
Will the CJEU follow the Advocate General’s opinion? Paul Harris, Head of Litigation at Dehns, takes a look…
The Patent Prosecution Highway (PPH) provides a mechanism for accelerating examination of a patent application at a second patent office, if examination work has already been conducted at a first patent office with whom a PPH agreement is in place. If claims of an application have been found acceptable by a first office (often the office of first filing), accelerated examination of a corresponding application at a second office may be requested. The PPH allows a second patent office to make use of relevant work already conducted by a first office when examining an application.
Subscribe here for updates on IP news, events and webinars.
|